Baricitinib Backed for Approval for Alopecia Areata in the EU
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib, a Janus kinase (JAK) inhibitor, for the […]
Read more